A. Serradimigni

发表

Amiodarone and desethylamiodarone elimination kinetics following withdrawal of long-term amiodarone maintenance therapy.

R. Bruno, J. Cano, D. Marchiset, 1985, Biopharmaceutics & drug disposition.

[Myocardium and plasma levels of amiodarone and its N-monodeethylated metabolite].

J. Cano, D. Marchiset, A. Serradimigni, 1983, Therapie.

Percutaneous transvenous caval interruption with the “LGM” filter: early results of a multicenter trial

J. Lefebvre, J. Ricco, Y. Biron, 1988, Annals of vascular surgery.

DISCREPANCIES BETWEEN VENOGRAPHY AND REAL TIME B MODE ULTRASOUND IMAGING IN THE DIAGNOSIS OF DEEP VEIN THROMBOSIS

A. Elias, A. Serradimigni, P. Villain, 1987 .

[Intravenous thrombolysis in myocardial infarction. Influence of the quality of the anticoagulation on the early recurrence rate of angina or infarction].

J. Bonnet, P. Djiane, A. Serradimigni, 1988, Archives des maladies du coeur et des vaisseaux.

Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis

M. Alessi, P. Holvoet, D. Collen, 1987, Thrombosis and Haemostasis.

insulin and acute-phase response Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma

P. Vague, X. Thirion, P. Joly, 2011 .

CLINICAL RELEVANCE OF HIGH PAI-1 LEVEL IN PATIENTS WITH IDIOPATHIC/RECURRENT DEEP VENOUS THROMBOSIS

M. Alessi, I. Juhan-vague, A. Serradimigni, 1988 .

Methergin testing with angiographically normal coronary arteries.

J. Bonnet, P. Joly, P. Djiane, 1988, The American journal of cardiology.

[Prevalence of arterial hypertension and its treatment in 2,595 adults].

A. Serradimigni, A. Ebagosti, G. Costa, 1988, Archives des maladies du coeur et des vaisseaux.

Value of real time B mode ultrasound imaging in the diagnosis of deep vein thrombosis of the lower limbs.

A. Elias, M. Benichou, A. Serradimigni, 1987, International angiology : a journal of the International Union of Angiology.

Modifications in Coagulation Parameters Induced by Treatment Associating Urokinase (2000 u CTA/kg/h) with Heparin

A. Serradimigni, I. Juhan, M. Buonocore, 1979, Thrombosis and Haemostasis.

Assessment of D-dimer measurement by ELISA or latex methods in deep vein thrombosis diagnosed by ultrasonic duplex scanning

A. Elias, I. Juhan-vague, A. Serradimigni, 1990 .

Effects of cicletanine in the left circumflex coronary artery occlusion-reperfusion canine model of sudden death: analysis of 107 experiments using Cox's proportional hazards model.

P. Puddu, A. Serradimigni, P. Rolland, 1988, Drugs under experimental and clinical research.

Cicletanide Improves Outcome After Left Circumflex Coronary Artery Occlusion-Reperfusion in the Dog

P. Puddu, J. Cano, A. Serradimigni, 1986, Journal of cardiovascular pharmacology.

[Detection by echocardiography of a thrombus of the right cavities in acute pulmonary embolism].

M. Antar, A. Goudard, A. Elias, 1987, Archives des maladies du coeur et des vaisseaux.

[Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study (30 patients)].

R. Khalil, L. Milandre, A. Elias, 1990, La Revue de medecine interne.

Evidence for isosorbide dinitrate (ISDN) promoting effect on prostacyclin release by the lung and prostacyclin implication in ISDN-induced inhibition of platelet aggregation in humans.

J. Cano, A. Serradimigni, I. Juhan, 1984, Prostaglandins, leukotrienes, and medicine.

Molsidomine prevents post‐ischaemic ventricular fibrillation in dogs

P. Puddu, J. Cano, A. Serradimigni, 1986, British journal of pharmacology.

The circumflex coronary artery occlusion canine model of sudden death: methodology and electrocardiographic observations.

P. Puddu, A. Serradimigni, J. Guillen, 1986, Journal of electrocardiology.

[Course of pulmonary embolism].

M. Degeorges, A. Elias, A. Serradimigni, 1983, Journal des maladies vasculaires.

[Has the prognosis of recent myocardial infarction changed?].

P. Joly, P. Djiane, A. Serradimigni, 1987, Archives des maladies du coeur et des vaisseaux.

Treatment of serious heparin-induced thrombocytopenia by plasma exchange: report on 4 cases.

A. Elias, A. Serradimigni, I. Juhan, 1988, Thrombosis research.

Treatment of deep vein thrombosis with a very low molecular weight heparin (CY 222 - Choay): Thrombolysis and plasma fibrinolytic parameters

M. Alessi, A. Elias, I. Juhan-vague, 1988 .

Alteration in Prostacyclin and Prostaglandin E2 Production: Correlation with Changes in Human Aortic Atherosclerotic Disease

A. Serradimigni, P. Rolland, C. Mercier, 1984, Arteriosclerosis.

Plasma Plasminogen Activator Inhibitor‐1 in Angina Pectoris: Influence of Plasma Insulin and Acute‐phase Response

M. Alessi, P. Declerck, P. Vague, 1989, Arteriosclerosis.

Binding of 99mTc Plasminogen on Fibrin

F. Roux, I. Juhan-vague, A. Serradimigni, 1981, Thrombosis and Haemostasis.

[Thrombosis of the superior vena cava].

A. Serradimigni, M. Michailevsco, 1984, Journal des maladies vasculaires.

Intravenous streptokinase versus heparin in the acute stage of myocardial infarction. A prospective randomised trial in south-east France.

J. Bonnet, A. Serradimigni, J. Sainsous, 1986, Haemostasis.

[Detection of left intraventricular thrombi in the acute phase of myocardial infarction by 2-dimensional echocardiography. Apropos of 103 cases].

P. Djiane, M. Benichou, A. Serradimigni, 1983, Archives des maladies du coeur et des vaisseaux.

Intravenous thrombolysis in myocardial infarction. Influence of anticoagulation quality on the early recurrence rate of angina or infarction [THROMBOLYSE INTRAVEINEUSE DANS L'INFARCTUS DU MYOCARDE. INFLUENCE DE LA QUALITE DE L'ANTICOAGULATION SUR LE TAUX DE RECIDIVES PRECOCES D'ANGOR OU D'INFARCTUS]

J. Bonnet, P. Djiane, A. Serradimigni, 1988 .

Simultaneous modelling of mexiletine and hydroxy‐methyl‐mexiletine data after single‐ and multiple‐dose administration of a sustained‐release mexiletine formulation

A. Iliadis, R. Bruno, P. Djiane, 1992, Biopharmaceutics & drug disposition.

Time-dependence of clobazam and N-demethylclobazam kinetics in healthy volunteers.

J. Cano, A. Serradimigni, P. Coassolo, 1986, International journal of clinical pharmacology, therapy, and toxicology.

Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.

A. Serradimigni, S. Witchitz, 1989, Journal of human hypertension.

Acitretin (RO10-1670) and oral contraceptives: interaction study

J. Geiger, A. Durand, D. Hartmann, 2004, Archives of Dermatological Research.

Natural inhibitors of fibrinolysis.

I. Juhan-vague, A. Serradimigni, M. Aillaud, 1986, Haemostasis.

Comparison of bisoprolol with nifedipine for treatment of essential hypertension in the elderly: comparative double-blind trial.

A. Serradimigni, G. Amabile, 1987, European Heart Journal.

Amiodarone and digoxin for refractory fetal tachycardia.

P. Arnoux, J. Cano, P. Djiane, 1987, The American journal of cardiology.

Percutaneous transvenous caval interruption with the “LGM” filter: early results of a multicenter trial

J. Lefebvre, J. Ricco, Y. Biron, 1988 .

[Aortic dissection ruptured into the pulmonary artery in a patient with familial hypercholesterolemia].

G. Donnarel, V. Dor, P. Djiane, 1970, Archives des maladies du coeur et des vaisseaux.

Treatment of Venous Thrombosis and Pulmonary Embolism by Streptokinase

I. Juhan-vague, P. Djiane, A. Serradimigni, 1978, Angiology.

[The role of thrombolytics in the treatment of deep vein thrombosis of the legs].

P. Djiane, A. Serradimigni, A. Egré, 1978, Therapie.